Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Monoamine oxidase‐B inhibitors as potential neurotherapeutic agents: An overview and update
Rati Kailash Prasad Tripathi, Senthil Raja Ayyannan
Medicinal Research Reviews (2019) Vol. 39, Iss. 5, pp. 1603-1706
Closed Access | Times Cited: 106

Showing 1-25 of 106 citing articles:

Monoamine Oxidase-B Inhibitors for the Treatment of Parkinson’s Disease: Past, Present, and Future
Yuyan Tan, Peter Jenner, Shengdi Chen
Journal of Parkinson s Disease (2021) Vol. 12, Iss. 2, pp. 477-493
Open Access | Times Cited: 141
A comprehensive review of multi-target directed ligands in the treatment of Alzheimer’s disease
Chandni Pathak, Uma D. Kabra
Bioorganic Chemistry (2024) Vol. 144, pp. 107152-107152
Closed Access | Times Cited: 42
Chalcones: Unearthing their therapeutic possibility as monoamine oxidase B inhibitors
Paolo Guglielmi, Bijo Mathew, Daniela Secci, et al.
European Journal of Medicinal Chemistry (2020) Vol. 205, pp. 112650-112650
Closed Access | Times Cited: 71
Recent advances in dopaminergic strategies for the treatment of Parkinson’s disease
Qi Mao, Wangzhi Qin, Ao Zhang, et al.
Acta Pharmacologica Sinica (2020) Vol. 41, Iss. 4, pp. 471-482
Open Access | Times Cited: 70
High-throughput discovery of highly selective reversible hMAO-B inhibitors based on at-line nanofractionation
Yu Fan, Jincai Wang, Jingyi Jian, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 4, pp. 1772-1786
Open Access | Times Cited: 9
Practical Three-Component Regioselective Synthesis of Drug-Like 3-Aryl(or heteroaryl)-5,6-dihydrobenzo[h]cinnolines as Potential Non-Covalent Multi-Targeting Inhibitors To Combat Neurodegenerative Diseases
Hossein Mousavi, Mehdi Rimaz, Behzad Zeynizadeh
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 9, pp. 1828-1881
Closed Access | Times Cited: 8
Molecular pathways: the quest for effective MAO-B inhibitors in neurodegenerative therapy
Mega O. Oyovwi, Onoriode Andrew Udi, Adedeji David Atere, et al.
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access | Times Cited: 1
Systematic Review on Parkinson’s Disease Medications, Emphasizing on Three Recently Approved Drugs to Control Parkinson’s Symptoms
Palanisamy Sivanandy, Tan Choo Leey, Tan Chi Xiang, et al.
International Journal of Environmental Research and Public Health (2021) Vol. 19, Iss. 1, pp. 364-364
Open Access | Times Cited: 46
Deciphering the detailed structure–activity relationship of coumarins as Monoamine oxidase enzyme inhibitors—An updated review
Vishal Payyalot Koyiparambath, Prayaga Rajappan Krishnendu, T. M. Rangarajan, et al.
Chemical Biology & Drug Design (2021) Vol. 98, Iss. 4, pp. 655-673
Closed Access | Times Cited: 43
Development of bromo- and fluoro-based α, β-unsaturated ketones as highly potent MAO-B inhibitors for the treatment of Parkinson's disease
Mohamed A. Abdelgawad, Jong‐Min Oh, Della Grace Thomas Parambi, et al.
Journal of Molecular Structure (2022) Vol. 1266, pp. 133545-133545
Closed Access | Times Cited: 34
Calycosin and 8-O-methylretusin isolated from Maackia amurensis as potent and selective reversible inhibitors of human monoamine oxidase-B
Jong‐Min Oh, Hyun‐Jae Jang, Won Jun Kim, et al.
International Journal of Biological Macromolecules (2020) Vol. 151, pp. 441-448
Closed Access | Times Cited: 43
Synthesis of novel benzothiazole derivatives and investigation of their enzyme inhibitory effects against Alzheimer's disease
Şevval Karaca, Derya Osmani̇ye, Begüm Nurpelin Sağlık, et al.
RSC Advances (2022) Vol. 12, Iss. 36, pp. 23626-23636
Open Access | Times Cited: 26
Drug Development for Alzheimer’s and Parkinson’s Disease: Where Do We Go Now?
Lisa Sequeira, Sofia Benfeito, Carlos Fernandes, et al.
Pharmaceutics (2024) Vol. 16, Iss. 6, pp. 708-708
Open Access | Times Cited: 5
New Aspects of Monoamine Oxidase B Inhibitors: The Key Role of Halogens to Open the Golden Door
Bijo Mathew, Simone Carradori, Paolo Guglielmi, et al.
Current Medicinal Chemistry (2020) Vol. 28, Iss. 2, pp. 266-283
Closed Access | Times Cited: 37
Targeting the Redox Landscape in Cancer Therapy
Dilip Narayanan, Sana Ma, Dennis Özcelik
Cancers (2020) Vol. 12, Iss. 7, pp. 1706-1706
Open Access | Times Cited: 34
Trimethoxylated Halogenated Chalcones as Dual Inhibitors of MAO-B and BACE-1 for the Treatment of Neurodegenerative Disorders
Vishal Payyalot Vishal, Jong‐Min Oh, Ahmed Khames, et al.
Pharmaceutics (2021) Vol. 13, Iss. 6, pp. 850-850
Open Access | Times Cited: 31
Combined 3D-QSAR and docking analysis for the design and synthesis of chalcones as potent and selective monoamine oxidase B inhibitors
Marco Mellado, César González, Jaime Mella, et al.
Bioorganic Chemistry (2021) Vol. 108, pp. 104689-104689
Closed Access | Times Cited: 30
Mitochondria targeting fluorescent probe for MAO-A and the application in the development of drug candidate for neuroinflammation
Jia‐Rong Wu, Chaoyan Han, Xudong Cao, et al.
Analytica Chimica Acta (2022) Vol. 1199, pp. 339573-339573
Closed Access | Times Cited: 22
Resveratrol-based compounds and neurodegeneration: Recent insight in multitarget therapy
Marialuigia Fantacuzzi, Rosa Amoroso, Simone Carradori, et al.
European Journal of Medicinal Chemistry (2022) Vol. 233, pp. 114242-114242
Closed Access | Times Cited: 22
Review of β‐carboline and its derivatives as selective MAO‐A inhibitors
Feba Benny, Sunil Kumar, Jayalakshmi Jayan, et al.
Archiv der Pharmazie (2023) Vol. 356, Iss. 7
Closed Access | Times Cited: 12
A structural approach to investigate halogen substituted MAO-B inhibitors using QSAR modeling, molecular dynamics, and conceptual DFT analysis
Naseer Maliyakkal, Iqrar Ahmad, Sunil Kumar, et al.
Journal of Saudi Chemical Society (2023) Vol. 27, Iss. 4, pp. 101675-101675
Open Access | Times Cited: 11
A Comprehensive Review of The Molecular Dynamic Study Of Chalcones, Coumarins and Chromones as Selective MAO‐B Inhibitors [2015‐Till Date]
Riya Rachel Thomas, Namitha Chandran, Della Grace Thomas Parambi, et al.
ChemistrySelect (2024) Vol. 9, Iss. 27
Closed Access | Times Cited: 4
Exploration of novel triazolo-thiadiazine hybrids of deferasirox as multi-target-directed anti-neuroinflammatory agents with structure–activity relationship (SAR): a new treatment opportunity for Alzheimer's disease
Syed Shakir, Umer Rashid, Marryum, et al.
RSC Advances (2025) Vol. 15, Iss. 1, pp. 101-118
Open Access
Design, synthesis, and neuroprotective activity of salidroside-based dual inhibitors of selective monoamine oxidase B and amyloid-β aggregation
Juan Zhang, Kongkai Zhu, Kaiming Wang, et al.
Medicinal Chemistry Research (2025)
Closed Access
A multi enzyme study reviewing the role of target enzymes in Alzheimer’s disease and unveiling potential inhibitors with insights on their present and future assessment
Sanaa Zaki, Samiullah Khan, Ruhi Ali
Medicinal Chemistry Research (2025)
Closed Access
Page 1 - Next Page

Scroll to top